ramipril
Commercial- Indications
- Hypertension
Company intelligence / Profile preview
No clinical trial data typical of pharmaceutical companies. Products are FDA-listed as homeopathics but lack large-scale clinical validation per standard drug development pathways. The company has developed over 500 natural homeopathic medicines since its founding. In the past faced regulatory scrutiny regarding claims made about certain products such as AddictaPlex. Products remain available on the market.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on King Bio.